Katy Murray

715 total citations
17 papers, 237 citations indexed

About

Katy Murray is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Katy Murray has authored 17 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 4 papers in Oncology. Recurrent topics in Katy Murray's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Pregnancy and Medication Impact (4 papers). Katy Murray is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Pregnancy and Medication Impact (4 papers). Katy Murray collaborates with scholars based in United Kingdom, United States and Italy. Katy Murray's co-authors include Michael D. Geschwind, David Hunt, Robert Will, Richard Knight, Babak Soleimani, Sarah Cooper, Patricia A. Kelly, Mark Woodhall, Dawn Everington and David Summers and has published in prestigious journals such as Annals of Neurology, BMJ Open and Multiple Sclerosis Journal.

In The Last Decade

Katy Murray

14 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katy Murray United Kingdom	7	116	86	85	52	30	17	237
Gianmarco Bellucci Italy	8	38 0.3×	84 1.0×	110 1.3×	14 0.3×	26 0.9×	18	213
Clarice Monteiro Brazil	9	48 0.4×	26 0.3×	90 1.1×	57 1.1×	131 4.4×	16	307
Lev Brylev Russia	9	43 0.4×	55 0.6×	37 0.4×	11 0.2×	18 0.6×	31	181
Lucía Alonso-Magdalena Sweden	9	27 0.2×	27 0.3×	107 1.3×	19 0.4×	38 1.3×	16	204
D. Travaglini Italy	6	27 0.2×	47 0.5×	42 0.5×	8 0.2×	21 0.7×	8	121
Vera Fominykh Russia	8	33 0.3×	45 0.5×	21 0.2×	12 0.2×	17 0.6×	24	138
Maria Malentacchi Italy	9	24 0.2×	74 0.9×	101 1.2×	9 0.2×	20 0.7×	17	182
Verónica Rivas‐Alonso Mexico	9	22 0.2×	137 1.6×	151 1.8×	15 0.3×	35 1.2×	29	290
David Reyes‐Leiva Spain	8	22 0.2×	70 0.8×	25 0.3×	11 0.2×	15 0.5×	20	168
Wajih Bukhari Australia	4	16 0.1×	72 0.8×	92 1.1×	23 0.4×	20 0.7×	6	152

Countries citing papers authored by Katy Murray

Since Specialization

Citations

This map shows the geographic impact of Katy Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Murray more than expected).

Fields of papers citing papers by Katy Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Murray. The network helps show where Katy Murray may publish in the future.

Co-authorship network of co-authors of Katy Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Murray. A scholar is included among the top collaborators of Katy Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Murray. Katy Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Dobson, Ruth, Tarunya Arun, James Varley, et al.. (2025). Approach to JCV testing with natalizumab biosimilar: a UK consensus statement. Multiple Sclerosis and Related Disorders. 100. 106541–106541.

Meijboom, Rozanna, Peter Foley, Niall MacDougall, et al.. (2024). Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration. Brain Communications. 6(5). fcae278–fcae278.

Rashid, Waqar, Olga Ciccarelli, Siobhan M Leary, et al.. (2024). Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance. Practical Neurology. 25(1). 18–24. 3 indexed citations

Wiles, Kate, Azza Ismail, Surabhi Nanda, et al.. (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. Multiple Sclerosis Journal. 29(3). 395–406. 1 indexed citations

Dobson, Ruth, David Rog, Caroline Ovadia, et al.. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. Practical Neurology. 23(1). 6–14. 24 indexed citations

Williams, Anna, et al.. (2022). Multiple sclerosis, disease modifying therapies and pregnancy. British Journal of Neuroscience Nursing. 18(Sup3). S22–S26. 1 indexed citations

Huda, Saif, Daniel Whittam, Richard Jackson, et al.. (2021). Predictors of relapse in MOG antibody associated disease: a cohort study. BMJ Open. 11(11). e055392–e055392. 49 indexed citations

Rog, David, Helen Ford, Katy Murray, et al.. (2021). UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines. Multiple Sclerosis and Related Disorders. 56. 103272–103272. 4 indexed citations

Soleimani, Babak, Katy Murray, & David Hunt. (2019). Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis. Drug Safety. 42(8). 941–956. 15 indexed citations

10.

Geschwind, Michael D. & Katy Murray. (2018). Differential diagnosis with other rapid progressive dementias. Handbook of clinical neurology. 153. 371–397. 28 indexed citations

11.

Cotter, Jack, Shuna Colville, Francesca Cormack, et al.. (2018). Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care. Frontiers in Neurology. 9. 331–331. 17 indexed citations

12.

Murray, Katy. (2016). EMDR Resource Methods for Women With Breast Cancer. Journal of EMDR Practice and Research. 10(3). 176–188. 3 indexed citations

13.

Hamid, Shahd, Liene Elsone, Kerry Mutch, et al.. (2015). Tonic spasms and short myelitis in an elderly woman—unique onset of neuromyelitis optica. Practical Neurology. 15(6). 463–465. 1 indexed citations

14.

Murray, Katy. (2011). Container. Journal of EMDR Practice and Research. 5(1). 29–32. 1 indexed citations

15.

Murray, Katy. (2011). Questions & réponses cliniques. Journal of EMDR Practice and Research. 5(3). 46–50. 1 indexed citations

16.

Heath, Craig A., Sarah Cooper, Katy Murray, et al.. (2010). Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease. Annals of Neurology. 67(6). 761–770. 52 indexed citations

17.

Ward, Helen, Dawn Everington, Simon Cousens, et al.. (2007). Risk factors for sporadic Creutzfeldt–Jakob disease. Annals of Neurology. 63(3). 347–354. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact